Assessment of Antibody and T-Cell Responses to the SARS-CoV-2 Virus and Omicron Variant in Unvaccinated Individuals Recovered From COVID-19 Infection in Wuhan, China
Open Access
- 27 April 2022
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 5 (4) , e229199
Abstract
The SARS-CoV-2 Omicron variant, which harbored 32 mutations in spike glycoproteins (S),1 raised concern over the virus escaping from immunity induced by vaccination or natural infection.2,3 However, the full extent to which the Omicron variant evades existing vaccine- or infection-derived antibodies, especially memory T-cell responses, has not been well characterized. In this cohort study, we assessed the antibody and T-cell responses to SARS-CoV-2 Wuhan and Omicron strains in individuals recovered from COVID-19.Keywords
This publication has 4 references indexed in Scilit:
- The significant immune escape of pseudotyped SARS-CoV-2 variant OmicronEmerging Microbes & Infections, 2021
- Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fearBMJ, 2021
- 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort studyThe Lancet, 2021
- SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipientsScience Immunology, 2021